# ERDERA Catalysing Collaborative Research for Recently Identified Rare Diseases

**Funder:** ANR
**Consortium:** Required — transnational collaborative research consortium addressing a recently identified rare disease
**Frequency:** Annual
**Next round:** 2026-12
**Eligible countries:** AT, BE, BG, CA, EE, FR, HU, IE, IT, LV, LT, LU, NO, PL, PT, CZ, RO, SK, ES, SE, TR
**Official call:** https://erdera.org/funding/
**Last updated:** 8 Nov 2026

## Eligibility & scope

Third ERDERA call funding transnational research on rare diseases first reported in peer-reviewed literature since 2010 and registered (or in registration) in Orphanet; covers natural history studies, biomarker validation, disease models, and pathophysiology research.

## Summary

This ERDERA call, administered nationally by ANR, funds transnational research consortia studying rare diseases first described in peer-reviewed literature since 2010 and listed (or pending listing) in Orphanet. Eligible projects cover natural history studies, biomarker validation, disease modelling, and pathophysiology research. The call opens in December 2026 and closes in June 2027, and participation requires partners from the eligible country list spanning Europe, Canada, and Turkey.

## Who should apply

- Researchers studying rare diseases first reported in literature since 2010
- Groups whose disease of interest is registered or in registration with Orphanet
- Teams working on natural history, biomarkers, disease models, or pathophysiology
- Consortia with partners based in the eligible countries listed by ERDERA
- Applicants able to coordinate a transnational collaborative research project

## Key dates

- Call opens December 2026 and closes June 2027
- Annual call frequency, with the next expected round in December 2026

## Tips for applicants

- Confirm the disease's Orphanet registration status (or submit evidence it is in registration) before applying, since this is a hard eligibility gate.
- Only partners from the listed eligible countries (including Canada and Turkey alongside EU/associated states) can join the consortium, check national co-funding rules early with each partner's own agency.
- Since ANR administers the French leg of this transnational call, French applicants should also check ANR's own submission portal requirements alongside the ERDERA call text.

## Frequently asked questions

### What diseases are eligible for the ERDERA recently identified rare disease call?

Rare diseases first reported in peer-reviewed literature since 2010 that are registered, or in the process of being registered, in Orphanet.

### When does the ERDERA call open and close?

The call opens in December 2026 and closes in June 2027.

### Which countries can participate in this ERDERA consortium call?

Applicants from Austria, Belgium, Bulgaria, Canada, Estonia, France, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Czechia, Romania, Slovakia, Spain, Sweden, and Turkey.

### Is a consortium required for this ERDERA call?

Yes, the call requires a transnational collaborative research consortium addressing a recently identified rare disease.

### How often does ERDERA run this call?

It runs annually, with this being the third call in the series and the next round expected to open in December 2026.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/anr-erdera-catalysing-collaborative-research-for-recen-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=anr-erdera-catalysing-collaborative-research-for-recen-2026).